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Objectives: Macrolides appear to modulate the inﬂammatory response in Cystic
ﬁbrosis (CF) patients and could inﬂuence oxidative stress. The objective was to
assess levels of inﬂammation and oxidation biomarkers and evaluate whether there
is an association with the intake of macrolides.
Methods: A cross-sectional descriptive study. Clinical and radiological severity
parameters were collected (exacerbations, Bahlla scoring system, amount of sputum,
spirometry) and inﬂammatory (interleukin-6, TNF-a and CRP) and oxidative stress
(total antioxidant capacity [TAC], catalase [CAT] activity, superoxide dismutase
[SOD] activity, glutathione peroxidase [GPx] activity, thiobarbituric acid reactive
substances [TBARs, lipid peroxidation] and Isoprostanes) activity markers were
measured.
Results: 36 clinically stable patients (mean age 27.8) and 41 controls of similar age,
sex and BMI were recruited. 23 (63.8%) patients were treated with azithromycin.
CF subjects had signiﬁcantly higher levels of IL-6, TNF-a and CRP, TBAs, iso-
prostanes and lower SOD activity than the controls. Patients who were treated with
azithromycin had a clinically more severe disease (greater number of exacerbations,
worst Bahlla score, %FEV1, higher percentage of Homozygous F508del, higher
percentage of chronic colonization), despite which they presented signiﬁcantly lower
levels of TNF-a (3.1±0.2 vs. 4.4±2.2, p< 0.05). There were no differences in the
other parameters analysed.
Conclusion: Use of azithromycin appears to modulate inﬂammatory response in
CF patients and is associated with a decrease in TNF-alpha levels at systemic level
without changes in oxidation parameters.
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Objectives: Infections with non-tuberculous mycobacteria, especially Mycobac-
terium abscessus (MABSC) are frequently observed in patients with cystic ﬁbro-
sis (CF). MABSC can cause chronic infection with severe clinical manifestations.
So far no immunological or serological tests for the detection MABSC infections
are available.
Methods: The aim of this study is to establish a speciﬁc immunological test
for the detection of MABSC infections in children with CF. Therefore we per-
formed whole blood in vitro restimulation with puriﬁed protein derivate (PPD) of
MABSC (Abscessin) to determine T-cell immunity against previous and current
mycobacterial infections in CF patients and age-matched controls. Due to cross-
reactivity of anti-mycobacterial immunity and to distinguish immunity against other
possible mycobacterial infections, PPDs of M. avium (Sensitin) and M. tuberculosis
(tuberculin) have been used concomitantly. Cytokines as well as the phenotype
of MABSC speciﬁc T cells were determined by ﬂow cytometry. All CF patients
underwent routine microbiological tests for NTM according to the ATS criteria.
Results: Initial results of CF patients (n = 28) revealed four conﬁrmed NTM-positive
cases who had positive immune responses against MABSC. Of 24 CF patients with
so far negative NTM cultures, ten showed immunity against NTM. In these cases
previously eradicated NTM infections may have occurred. Ongoing studies aim at
establishing NTM-speciﬁc PCR analysis from sputum to exclude false negative
NTM cultures as another possible explanation for divergent result. In addition
phenotypic T-cell characterization will reveal whether acute and previous NTM
infection can be distinguished.
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Objectives: Increased P. aeruginosa (PA) virulence may contribute to pulmonary exacerbations in
CF. The aims of this ongoing study are to (1) investigate the impact of culture conditions (aerobic
vs. anaerobic) on in vivo PA virulence and (2) determine if there is a difference in the virulence of
PA cultured from CF patients during periods of clinical stability and infective exacerbation.
Methods: PA (n = 8) recovered at 2 different time points from one CF patient, when clinically stable,
and a control strain (Pa01) have been studied. Each isolate was grown under aerobic and anaerobic
conditions. Batches of Galleria mellonella larva (n = 10) were infected with each isolate (inoculum
of 107 CFU/ml). Virulence was determined by calculating percentage larvae survival and haemocyte
(homologue of neutrophils) density at 24 hours.
Results: Survival (X 2 = 17.827, P < 0.001, McNemar’s test, Table) and haemocyte density (P = 0.031,
Wilcoxon signed rank test) were lower when larvae were infected with PA grown anaerobically.
Table: Larvae survival at 24 hours following infection
Survival (%)
Aerobic Anaerobic
Isolate 1 0 10
Isolate 2 50 10
Isolate 3 30 40
Isolate 4 80 60
Isolate 5 20 0
Isolate 6 30 10
Isolate 7 90 80
Isolate 8 0 0
Control (Pa01) 0 0
Conclusion: These results suggest that PA is more virulent to larvae when grown anaerobically. Lower
haemocyte density is hypothesised to be the result of premature cell lysis due to overwhelming infec-
tion within larvae. Ongoing work includes investigating if PA virulence changes during exacerbations
and molecular typing to characterize the strains and their virulence genes.
Work supported by AMMI Canada/Pﬁzer Post-Residency Fellowship and CF Canada.
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Objectives: Bacterial LPS can elicit a potent response from the eukaryotic innate
immune system and is recognised by host receptors such as TLR-4. The aim of this
study was to determine the effects of Prevotella spp. LPS on pro-inﬂammatory cytokine
production by THP-1 monocytic cells.
Methods: LPS from a P. intermedia type strain and a CF clinical P. denticola isolate
were used. TLR grade E. coli LPS was included as a control. THP-1 cells were
stimulated with puriﬁed P. intermedia LPS (10 ng/ml), unpuriﬁed P. denticola LPS
(2mg/ml), and E. coli LPS (100 ng/ml) for 3, 6, 12, and 24 hours. Pro-inﬂammatory
cytokines in cell free supernatants were assayed and cell viability determined at each
time point.
Results: Peak THP-1 cell pro-inﬂammatory response to both Prevotella spp. and E. coli
LPS was of a similar order of magnitude with regard to 4 pro-inﬂammatory cytokines.
Table: THP-1 cell peak response post stimulation with LPS
Cytokine levels (pg/ml), mean (SD)
Treatment IL-8 IL-1b IL-6 TNF-a
P. intermedia 8397 (303.5) 162 (4.6) 14 (1.3) 3863 (276.9)
E. coli 9006 (775.9) 71 (0.1) 42 (0.7) 1199 (1.3)
P. denticola 1662 (162.8) 34 (0.7) 10 (0.9) 851 (11.3)
Unstimulated 10 (0.3) Not detected 0.5 (0.2) 2.9 (0.2)
Peak values for IL-8, IL-1b, and IL-6 occurred at 6−12 hours in response to Pre-
votella spp. LPS, and at 24 hours in response to E. coli LPS.
Conclusions: The presence of Prevotella spp. within the CF lung may, via the
stimulation of monocytic cells, contribute to the pathogenesis of CF airways disease.
Work funded by DEL NI, HSC R&D, PHA NI, and the MRC via a US–Ireland
Partnership Grant.
